Imisopasem manganese

Drug Profile

Imisopasem manganese

Alternative Names: M 40403; Superoxide dismutase mimic - MetaPhore

Latest Information Update: 27 May 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator MetaPhore Pharmaceuticals
  • Developer ActivBiotics; MetaPhore Pharmaceuticals
  • Class Analgesics; Anti-inflammatories; Anti-ischaemics; Macrocyclic compounds; Oxidoreductases; Small molecules
  • Mechanism of Action Superoxide dismutase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Mucositis
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Cancer; Cancer pain; Pain; Postoperative pain; Stomatitis

Most Recent Events

  • 02 Apr 2008 ActivBiotics sells its intellectual property assets including drug product candidates
  • 07 Mar 2008 Imisopasem manganese received Orphan Drug status for Stomatitis in USA
  • 05 Feb 2008 Imisopasem manganese received Orphan Drug status for Stomatitis in European Union
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top